On the 13th of September, 2022 launched an ambitious expansion of the National Institute for Bioprocessing Research and Training’s (NIBRT) current site in Dublin, Ireland.
Tánaiste Leo Varadkar and Martin Shanahan, CEO of IDA Ireland attended today’s announcement at NIBRT’s facility in Dublin.
The construction project is expected to be completed and fully operational in the second quarter of 2023 and aims to increase NIBRT’s capacity to carry out manufacturing-focused research and training.
This €21 million project is funded by the Irish Government through IDA Ireland and incorporates 1,800 m2 of new space, including five research laboratories and state-of-the-art training suites, into the existing NIBRT facility that will be dedicated to advanced therapeutics.
The new facility will accommodate around twenty-five new researchers and training staff. It will serve new and existing NIBRT clients by providing research solutions to manufacturing challenges and staff training in the manufacturing of these highly innovative and complex medicines.
Find the full press release in the link below.